Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9036)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2021 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sharma SP, Suk KT, Kim DJ. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J Gastroenterol 2021; 27(37): 6161-6179 [PMID: 34712025 DOI: 10.3748/wjg.v27.i37.6161] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i37/6161.htm |
| Number | Citing Articles |
| 1 |
Helmut K. Seitz, Bernardo Moreira, Manuela G. Neuman. Pathogenesis of Alcoholic Fatty Liver a Narrative Review. Life 2023; 13(8): 1662 doi: 10.3390/life13081662
|
| 2 |
Dongmei Qin, Chang Han, Yuefeng Gao, Hong Li, Liping Zhu. Lactucin reverses liver fibrosis by inhibiting TGF-β1/STAT3 signaling pathway and regulating short-chain fatty acids metabolism. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70253-5
|
| 3 |
Yan Li, Wen-Cheng Liu, Bing Chang. Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases. World Journal of Gastroenterology 2022; 28(26): 3279-3281 doi: 10.3748/wjg.v28.i26.3279
Abstract(739) |
Core Tip(576) |
Full Article(HTML)(1882)
|
Full Article (PDF)-1910K(228)
|
Full Article (Word)-102K(86)
|
Audio-513K(4)
|
Peer-Review Report-185K(65)
|
Answering Reviewers-176K(71)
|
Times Cited (0)
|
Total Visits (5197)
|
Open
|
| 4 |
Li-Ran Zhu, Shan-Shan Li, Wan-Qun Zheng, Wei-Jian Ni, Ming Cai, Hai-Peng Liu. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1086078
|
| 5 |
Xiao-Yu He, Yu-Xian Zhu, Xiao-Qin Jiang, Fu-Rong Zhu, Yi-Juan Luo, Yu-Yang Qiu, Zi-Rui Huang, Bin Liu, Feng Zeng. Probiotics-Fermented Grifola frondosa Total Active Components: Better Antioxidation and Microflora Regulation for Alleviating Alcoholic Liver Damage in Mice. International Journal of Molecular Sciences 2023; 24(2): 1406 doi: 10.3390/ijms24021406
|
| 6 |
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong-Joon Kim, Ki-Tae Suk. Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role. Biomedicines 2022; 10(3): 550 doi: 10.3390/biomedicines10030550
|
| 7 |
Pin Gong, Hui Long, Yuxi Guo, Zhineng Wang, Wenbo Yao, Jing Wang, Wenjuan Yang, Nan Li, Jianwu Xie, Fuxin Chen. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress. Journal of Ethnopharmacology 2024; 318: 116927 doi: 10.1016/j.jep.2023.116927
|
| 8 |
Zhengzheng Gao, Lina Dai, Haifeng Zhang, Liang Cheng. Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/7606716
|
| 9 |
Matthias Held, Jochen Gläser. Exploring publication networks with a local cohesion-maximizing algorithm. Quantitative Science Studies 2024; 5(3): 681 doi: 10.1162/qss_a_00314
|
| 10 |
Heng-Tong Han, Wei-Lin Jin, Xun Li. Mesenchymal stem cells-based therapy in liver diseases. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00088-x
|
| 11 |
Sevag Hamamah, Roxana Gheorghita, Andrei Lobiuc, Ioan-Ovidiu Sirbu, Mihai Covasa. Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1060581
|
| 12 |
Yue Leng, Fang Wang, Changbao Chen, Xilin Wan, Xinyang Li, Huan Wang, Shumin Wang. Protective Effect of Ganoderma lucidum Spore Powder on Acute Liver Injury in Mice and its Regulation of Gut Microbiota. Frontiers in Bioscience-Landmark 2023; 28(2) doi: 10.31083/j.fbl2802023
|
| 13 |
Chao Yang, Jiale Wu, Ligang Yang, Qiaosheng Hu, Lihua Li, Yafang Yang, Jing Hu, Da Pan, Qing Zhao. Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72909-8
|
| 14 |
Yoko Matsumura, Masahiro Kitabatake, Shin-ichi Kayano, Toshihiro Ito. Dietary Phenolic Compounds: Their Health Benefits and Association with the Gut Microbiota. Antioxidants 2023; 12(4): 880 doi: 10.3390/antiox12040880
|
| 15 |
Andriy Dorofeyev, Mykola Rudenko, Теtiana Cheverda. STATE OF THE GUT MICROBIOTA IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE WITH TYPE 2 DIABETES MELLITUS. Proceeding of the Shevchenko Scientific Society. Medical Sciences 2022; 69(2) doi: 10.25040/ntsh2022.02.12
|
| 16 |
Gabriel Henrique Hizo, Pabulo Henrique Rampelotto. The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies. Microorganisms 2023; 11(12): 2999 doi: 10.3390/microorganisms11122999
|